leisure time -WSS

leisure time

author：comprehensive 2025-09-27 23:01:00 - browse：75

Lauren Gavron walking with prosthetic in a lab at the University of Pittsburgh. Courtesy Nathan Langer/UPMC & Pitt Health Sciences

For years, Lauren Gavron relied on oxycodone to quiet the pain in her missing lower left limb. But she hated the fog that came with it, preventing her from feeling comfortable enough to drive.

When researchers at the University of Pittsburgh delivered electric jolts to her spine in 2021, the Duquesne, Pennsylvania resident was shocked to feel that pain temporarily melt away — and to feel sensation in her prosthetic foot, improving her walk and balance.

“You really wouldn’t believe it,” Gavron, 67, said. “As soon as the pain would start, it just all went away.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： The stability of $0 premiums in Medicare Advantage

WSS

As a primary care physician, here's how I hope to partner with AI

Some top drug companies are starting to take action on climate

CRISPR base editing slashes cholesterol levels in monkeys

Listen: More tumult at BIO & coercive care for sickle cell patients

UnitedHealth argues against case alleging wrongful AI care denials

6 solutions to address cancer drug shortages and others

focus

leisure time

entertainment

After affirmative action ruling, medical educators look to 'holistic review'

Readout Newsletter: Biotech news, Wall Street disappointment, Lilly's drug delays

Malaria cases in Florida and Texas: Here’s what you need to know

Study finds gene variants tied to breast cancer risk in Black women

23andMe had bad news about my health. I wish a person had delivered it

Flu, Covid vaccination rates decline, new survey data show

Novavax promises a turnaround & Lilly roils the obesity market

ASCO eve: Let’s set the table for this year's meeting

United colonoscopy coverage change 'may cost lives,' doctors say

Study points to new risk in gene therapy death of Terry Horgan

Wikipedia

Some top drug companies are starting to take action on climate

CDC picks Alphabet's Verily for wasterwater surveillance contract

FDA sees ‘potential systemic bias’ in Amgen’s KRAS drug trial

European officials brace for rough respiratory virus season

Study finds gene variants tied to breast cancer risk in Black women

Eyeing GLP

focus

focus

hotspot

focus